Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Overweight × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Neoplasms 15 Lung Neoplasms 9 Colonic Neoplasms 9 Breast Neoplasms 9 Brain Neoplasms 6 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Respiratory Aspiration 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pituitary Neoplasms 3 Neoplastic Cells, Circulating 3 Hypoxia 3 Emergence Delirium 3 Carcinoma, Hepatocellular 3 Agnosia 3 Postoperative Complications 2 Patient Satisfaction 2 Pain 2 Ovarian Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Leukemia 2 Delirium 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Abdominal Neoplasms 2 Uterine Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Nodule 1

Interventions

Nutrition Assessment 5 Exercise 5 Counseling 5 Methods 3 Diet Therapy 3 Caloric Restriction 3 Resistance Training 2 Naltrexone 2 Megestrol Acetate 2 Exenatide 2 Educational Status 2 Early Intervention, Educational 2 Diet 2 Bupropion 2 Blood Specimen Collection 2 sultamicillin 1 semaglutide 1 licogliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Ursodeoxycholic Acid 1 Urine Specimen Collection 1 Tobacco Use Cessation Devices 1 Tirzepatide 1 Tablets 1 Surveys and Questionnaires 1 Sucrose 1 Standard of Care 1 Psychology, Positive 1 Propofol 1 Progestins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518929 2024-06-07

SpO2

RenJi Hospital

Phase 4 Completed

GastrointestinalOther

Obesity, Stomach Neoplasms, Stomach Ulcer, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡